Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N D'Haene

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Revue Medicale De Bruxelles|May 20, 2017
[Next generation sequencing]M Le Mercier, N D'Haene, S Rorive, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 26, 2010
Antenatal embolization of a large chorioangioma by percutaneous Glubran 2 injectionK Gajewska, A Herinckx, A Holoye, et al.
Revue Medicale De Bruxelles|May 20, 2017
[How molecular biology can improve the clinical diagnosis of gliomas?]N D'Haene, O Blanchard, N De Nève, et al.
Neuropathology and Applied Neurobiology|November 7, 2007
Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomasC Maris, S Rorive, F Sandras, et al.
AJNR. American Journal of Neuroradiology|December 15, 2007
Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsiesN Sadeghi, N D'Haene, C Decaestecker, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinomaA Rosoux, P Pauwels, F Duplaquet, et al.
British Journal of Cancer|August 21, 2015
IGF-IR: a new prognostic biomarker for human glioblastomaC Maris, N D'Haene, A-L Trépant, et al.
Journal of Neuro-Oncology|March 4, 2016
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Vandervorst, et al.
Journal of Neuro-Oncology|October 9, 2017
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Bouttens, et al.
ESMO Open|May 20, 2025
Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiativeG Raicevic Toungouz, R Alessandrello, P Giacomini, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Revue Medicale De Bruxelles|May 20, 2017
[Next generation sequencing]M Le Mercier, N D'Haene, S Rorive, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 26, 2010
Antenatal embolization of a large chorioangioma by percutaneous Glubran 2 injectionK Gajewska, A Herinckx, A Holoye, et al.
Revue Medicale De Bruxelles|May 20, 2017
[How molecular biology can improve the clinical diagnosis of gliomas?]N D'Haene, O Blanchard, N De Nève, et al.
Neuropathology and Applied Neurobiology|November 7, 2007
Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomasC Maris, S Rorive, F Sandras, et al.
AJNR. American Journal of Neuroradiology|December 15, 2007
Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsiesN Sadeghi, N D'Haene, C Decaestecker, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinomaA Rosoux, P Pauwels, F Duplaquet, et al.
British Journal of Cancer|August 21, 2015
IGF-IR: a new prognostic biomarker for human glioblastomaC Maris, N D'Haene, A-L Trépant, et al.
Journal of Neuro-Oncology|March 4, 2016
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Vandervorst, et al.
Journal of Neuro-Oncology|October 9, 2017
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Bouttens, et al.
ESMO Open|May 20, 2025
Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiativeG Raicevic Toungouz, R Alessandrello, P Giacomini, et al.
Pageof 3